openPR Logo
Press release

US Antidiabetics Drug Market Outlook 2022 Report

05-07-2018 05:55 AM CET | Health & Medicine

Press release from: Kuick Resarch

“US Antidiabetics Drug Market Outlook 2022” report highlights:

* US Diabetes Epidemiology
* US Antidiabetics Market Overview
* Key Marketed Antidiabetic Drugs in US
* US Biosimilar Insulin Market
* US Antidiabetics Drug Market Future Prospects

Download Report Sample Weblink:

For Report Sample Contact:

Table of Contents

Antidiabetics: Regimen for Diabetes Mellitus
1.1 Prologue Towards Diabetes
1.2 Preface to Antidiabetics

Antiquity of Managing Diabetes Mellitus
2.1 Trajectory from Diabetes to Insulin
2.2 Historical En Route towards Oral Diabetic Medication

Treatments Available for Diabetes Mellitus
3.1 Non-Pharmacological Approaches for Diabetes Mellitus
3.2 Pharmacological Approaches for Diabetes Mellitus

Cataloguing of Antidiabetic Agents
4.1 Antidiabetic: Oral Agents
4.1.1 Biguanides
4.1.2 Thiazolidinediones (TZDs)
4.1.3 Sulfonylureas
4.1.4 Meglitinides
4.1.5 andalpha;- Glucosidase Inhibitors
4.1.6 Dipeptidyl Peptidase-4 Inhibitor
4.1.7 Bile Acid Sequestrants (BAS)
4.1.8 Dopamine Agonist-2

Antidiabetic: Injectable Drugs
5.1 Insulin: A life saving Modality
5.2 Non-Insulin Alternatives for Diabetes Mellitus

US Diabetes Epidemiology
6.1 Prevalence of Type 1 and 2 Diabetes
6.2 Economic Burden Associated with Type 1 and 2 Diabetes: Productivity Loss and Medical Bills

US Antidiabetics Market Overview
7.1 Antidiabetic Injectable Market Trends in US
7.2 Antidiabetic Oral Drugs Market Trends in US
7.3 Commending Trends of Antidiabetics

US: Key Marketed Antidiabetic Drugs
8.1 Insulin Degludec (Tresiba)- Injection
8.2 Insulin Lispro - Injection
8.3 Insulin Inhalation(Afrezza) - Inhalation
8.4 Insulin Glargine (Toujeo) - Injection
8.5 Insulin Glulisine (Apidra) - Injection
8.6 Insulin Aspart (NovoLog) - Injection
8.7 Insulin Detemir (Levemir FlexTouch) - Injection
8.8 Insulin Glargine (Lantus) - Injection
8.9 Insulin Aspart/Insulin Protamine Aspart (NovoLog) - Injection

US Biosimilar Insulin Market: Glargine Basaglar andndash; The First “Biosimilar” Insulin
9.1 First Insulin Biosimilar
9.2 Impact of Basaglar Launch

US Antidiabetics Drug Market Dynamics
10.1 Accelerative Parameters
10.2 Major Challenges

US Antidiabetics Drug Market Future Prospects

Competitive Landscape
12.1 AstraZeneca
12.2 Bayer
12.3 Boehringer Ingelheim
12.4 Eli-Lilly
12.5 Johnson and Johnson
12.6 Merck
12.7 Novartis
12.8 Novo Nordisk
12.9 Sanofi
12.10 Takeda

Figure 1-1: Illustration of the Categories of Diabetes Mellitus
Figure 1-2: Percentage of Different types of Antidiabetics Used
Figure 2-1: Historical Pathway of oral Diabetic Medication
Figure 3-1: Control of Glucose Uptake during Muscle Working
Figure 4-1: Categorization of Oral Antidiabetics Approved in US
Figure 4-2: Chemical Structure of Metformin, Phenformin and Buformin
Figure 4-3: Illustration of the Sub-Categories of Sulfonylureas
Figure 5-1: Mechanism of Insulin in Regulation of Blood Glucose Levels
Figure 5-2: Differences between Diabetes Mellitus 1 and 2 over Insulin
Figure 5-3: Structure of Differentiation of Peptidic Insulin Analogs
Figure 5-4: Demonstration of Action Profiles of Insulin Analogue
Figure 5-5: Activity Profiles of Different Types of Insulin
Figure 5-6: Difference between Lantus and Levemir
Figure 6-1: US: Number of Type 1 Diabetes Incidence (Million), 2016 and 2022
Figure 6-2: US: Number of Type 2 Diabetes Incidence (Million), 2014 - 2022
Figure 6-3: US: Type 1 Diabetes Prevalence Rate (%), 2016 and 2022
Figure 6-4: US: Type 2 Diabetes Prevalence Rate (%), 2014 - 2022
Figure 6-5: US: Diabetes Prevalence Rate among Adults Aged 18+ (%), 2010 - 2016
Figure 6-6: US: Obesity Rate Among Adults Aged 18+ (%), 2010 - 2016
Figure 6-7: US: Percentage of Adults with Obesity by State (%), 2015
Figure 6-8: Illustration of Total Cost of Diabetes Expenditure
Figure 6-9: Annual Average Cost Of Diabetes per Person in US
Figure 6-10: US: Productivity Loss Due To Type 1 Diabetes (US$ Billion), 2014 - 2022
Figure 6-11: US: Productivity Loss Due To Type 2 Diabetes (US$ Billion), 2014 - 2022
Figure 6-12: US: Medical Cost for Type 1 Diabetes (US$ Billion), 2014-2022
Figure 6-13: US: Medical Cost for Type 2 Diabetes (US$ Billion), 2014-2022
Figure 7-1: Overview of Diabetic Drug Market Segmentation
Figure 7-2: US: Antidiabetics Drug Market (US$ Billion), 2014 - 2022
Figure 7-3: US: Share of Antidiabetics Drug Market in Total Drug Market Spending (US$ Billion), 2016
Figure 7-4: US - Percentage of Most Common Class of Antidiabetics Drugs
Figure 7-5: US andndash; Percentage of Generally Prescribed Anti-Diabetic Drugs (%)
Figure 8-1: US - Insulin Degludec (Tresiba) Injection Sales (US$ Million), 2016-2022
Figure 8-2: US -Insulin Lispro Injection Sales (US$ Million), 2016-2022
Figure 8-3: US - Insulin Glargine (Toujeo) Injection Sales (US$ Million), 2016-2022
Figure 8-4: US - Insulin Glulisine (Apidra) Injection Sales (US$ Million), 2016-2022
Figure 8-5: US - Insulin Detemir (Levemir FlexTouch) Injection Sales (US$ Million), 2016-2022
Figure 9-1: Comparison of Price of Insulin Lantus and Basaglar
Figure 10-2: Estimated Insulin Basaglar Sales in Diabetes
Figure 10-1: Major Accelerative Parameters for Antidiabetic Market in US
Figure 10-2: Estimated Impact of Increasing Trend in Obesity by 2020
Figure 10-3: Estimated Increase in Total Number with Diagnosed Diabetes till 2050
Figure 10-4: Major challenges in Antidiabetics Market
Figure 10-5: Important Challenges with the Use of Insulin
Figure 11-1: US: Share of Antidiabetics Drug Market in Total Drug Market Spending (US$ Billion), 2022
Figure 11-2: Illustration of Antidiabetic Drugs Under Development

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US Antidiabetics Drug Market Outlook 2022 Report here

News-ID: 1040634 • Views: 273

More Releases from Kuick Resarch

Bi-specific Antibodies For Enhanced Killing of the Foreign Cells Invaders
The availability of bi-specific antibodies has triggered a fundamental shift in the treatment paradigm for broad spectrum disease. The big pool of data available for the complex human system and its coupling with the advanced analytics tools have helped the researchers to come up with a treatment procedure that is unique and hold maximum promising outcomes for the huge percentage of patient population in the world. Bi-specific antibodies represent
Artificial Immune Modulation Therapy, An Upcoming Breakthrough in the Global Imm …
The platform provided by artificial immune modulation therapy comprises of a specific artificial matrix for the modulation of different antigen-presenting cells, which is an important part in the immune system. The methodology involved in the artificial immune modulation therapy represents simple yet powerful action against challenging mechanism of the cancer development and progression. The therapy involves engineering and administration of the artificial presenting cells to the patients so that
Exploitation of Immune Cells for Gaining Maximum Positive Outcomes in Cancer Mar …
The approach that has been focused by the cancer immunotherapies have helped in transforming the global cancer therapeutics market. Its arrival in the market has assisted the researchers to overcome all the challenges and short-imperative approach that has been delivered by the other commercially available cancer therapies. The fundamental principle of the immunotherapy which involves the cells of the immune cells holds great potential and huge difference in delivering promising
Global Cell Therapy Market To Surpass US$ 400 Billion In Opportunity By 2027 Wit …
"Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027" Report Highlights: • Global Cell Therapy Market Opportunity: More Than USD 40 Billion By 2027 • Cell Therapy Clinical Trial Insight by Indication, Company and Country • Global Cell Therapy Clinical Pipeline: 1000 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Cell Therapy Trials For COVID-19: 10 Cell Therapies • Global COVID-19 Cell Therapy Clinical Trials By Phase & Company • COVID-19 Impact Analysis on Global market &

All 5 Releases

More Releases for Figure

Figure Skating Equipment Market Report 2018: Segmentation by Type (Figure Skate …
Global Figure Skating Equipment market research report provides company profile for SP-Teri, Graf Skate, Riedell Shoes, Roces, American Athletic, Rollerblade, Winnwell, Dongguan King Line, Jackson Ultima, HD Sports(MK Blades, John Wilson), Edea, Risport Skates, Paramount Skates and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY
Figure Skating Equipment Sales Market Segmentation and Forecast to 2025
This report studies the global Figure Skating Equipment market status and forecast, categorizes the global Figure Skating Equipment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). The figure skating equipment includes the Figure Skate Boots, Figure Skate Blades and Figure
Global Leisure Boats Market Dynamic, Value, Figure, Forecast 2018-2025
Qyresearchreports include new market research report Global Leisure Boats Market Professional Survey Report 2018 to its huge collection of research reports. This report studies Leisure Boats in Global market,especially in North America,China,Europe,Southeast Asia,Japan and India,with production,revenue,consumption,import and export in these regions,from 2013 to 2018,and forecast to 2025. This report focuses on top manufacturers in global market,with production,price,revenue and market share for each manufacturer,covering Riva Sunseeker Ferretti Lurssen Azimut Wally Princess Pershing Free Sample of this report is available upon request @
Global Protective Packaging Market Dynamic, Value, Figure, Forecast 2018-2025
Qyresearchreports include new market research report Global Protective Packaging Market Professional Survey Report 2018 to its huge collection of research reports. This report studies Protective Packaging in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and
Global Figure Skating Equipment Market Size,Share : Industry Trends 2022
"The Report Global Figure Skating Equipment Market by Manufacturers, Countries, Type and Application, Forecast to 2022 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -" This report studies the figure skating equipment, which includes the Figure Skate Boots, Figure Skate Blades and Figure Skates. Not similar with the common shoes, people should run in and adapt to figure skating equipment, which means they
Long-lasting Performance Improvement with Key Figure Analysis
Vienna/Reutlingen, October 17, 2012 – Manz, a leading high-tech mechanical engineering company, is optimizing its processes in strategic sourcing in order to recognize the risks and potential associated with each supplier early on so that the sourcing department can react to them in time. POOL4TOOL’s customized eSolutions localize and analyze key figures that are relevant to the decision making process, and displays these figures in a comprehensive and transparent way.